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Title of rigorous thesis: Effect of selected sesquiterpenes on carbonyl reductase 1 activity 
in vitro 
Sesquiterpenes, the main components of plant essential oils, are integral parts of spices, 
traditional food and beverages. They are used in folk medicines, pharmaceutical industry as 
well as in cosmetics. Several sesquiterpenes possess interesting biological activities but they 
could interact with concurrently administered drugs via the modulation of activity and/or 
expression of  drug-metabolizing enzymes. Enzyme carbonyl reductase 1 (CBR1) is one 
of the enzymes participating in the metabolism of a number of endogenous and xenobiotic 
compounds. One of the CBR1 substrates is chemotherapeutic agent doxorubicin, which is 
metabolized by this enzyme to the less effective metabolite doxorubicinol, which is 
responsible for the doxorubicin cardiotoxicity. The aim of this rigorous thesis was to find out 
the ability of five selected sesquiterpenes (i.e. valencene, β-caryophyllene oxide, α-humulene, 
cis-nerolidol and trans-nerolidol) to affect the activity of CBR1 in vitro. The effect of studied 
substances on the activity of this enzyme was monitored in cytosolic fraction obtained from 
rat liver and also on recombinant human CBR1. Activity of CBR1 was in both cases assessed 
by method of Maté et al. (2008) using menadion as a substrate. The highest inhibitory effect 
was found in case of trans-nerolidol, which decreased CBR1 activity in cytosol by 14,3 % 
compared to the control. In case of human recombinant CBR1, no significant change in 
activity was observed. Taken together, the results of this study indicate that the selected 
sesquiterpenes valencene, β-caryophyllene oxide, α-humulene, cis-nerolidol  
and trans-nerolidol do not express considerable inhibitory effect towards CBR1. 
 
